<SEC-DOCUMENT>0001193125-21-005827.txt : 20210111
<SEC-HEADER>0001193125-21-005827.hdr.sgml : 20210111
<ACCEPTANCE-DATETIME>20210111081631
ACCESSION NUMBER:		0001193125-21-005827
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210111
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210111
DATE AS OF CHANGE:		20210111

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Magenta Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001690585
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38541
		FILM NUMBER:		21519350

	BUSINESS ADDRESS:	
		STREET 1:		100 TECHNOLOGY SQUARE
		STREET 2:		5TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-201-2700

	MAIL ADDRESS:	
		STREET 1:		100 TECHNOLOGY SQUARE
		STREET 2:		5TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d86590d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mgta="http://www.magentatx.com/20210111" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-01-11_to_2021-01-11">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-01-11_to_2021-01-11">0001690585</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="mgta-20210111.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-01-11_to_2021-01-11"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690585</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-11</xbrli:startDate> <xbrli:endDate>2021-01-11</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">FORM&#160;<ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-01-11_to_2021-01-11">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt:datemonthdayyearen">January&#160;11, 2021</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-01-11_to_2021-01-11">MAGENTA THERAPEUTICS,&#160;INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-01-11_to_2021-01-11">001-38541</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-01-11_to_2021-01-11">81-0724163</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction of<br />incorporation or organization)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br />Identification Number)</span></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-01-11_to_2021-01-11">100 Technology Square</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-01-11_to_2021-01-11">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:stateprovnameen">Massachusetts</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-01-11_to_2021-01-11">02139</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-01-11_to_2021-01-11">(857)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-01-11_to_2021-01-11">242-0170</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the <span style="white-space:nowrap">Form&#160;8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to <span style="white-space:nowrap">Rule&#160;14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to <span style="white-space:nowrap">Rule&#160;14d-2(b)&#160;under</span> the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to <span style="white-space:nowrap">Rule&#160;13e-4(c)&#160;under</span> the Exchange Act (17 CFR <span style="white-space:nowrap">240.13d-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-01-11_to_2021-01-11">Common Stock, $0.001 Par Value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-01-11_to_2021-01-11">MGTA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2021-01-11_to_2021-01-11" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following information and Exhibit&#160;99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;11, 2021, Magenta Therapeutics,&#160;Inc. issued a press release providing a business update including highlights of recent progress across several programs and platforms, preliminary unaudited financial results for the full year ended December&#160;31, 2020 and projected cash runway. The full text of the press release is furnished as Exhibit&#160;99.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;Exhibits: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following exhibit relating to Item 2.02 shall be deemed furnished, and not filed: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:94%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d86590dex991.htm">Press Release dated January&#160;11, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:10%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:89%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">MAGENTA THERAPEUTICS,&#160;INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">January&#160;11, 2021</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jason Gardner</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d86590dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g86590g0110020022160.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four
Ongoing and Planned Clinical Trials </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; <FONT STYLE="white-space:nowrap">MGTA-145:</FONT> Three Phase 2 clinical trials ongoing
or planned to evaluate <FONT STYLE="white-space:nowrap">MGTA-145,</FONT> a biologic used in combination with plerixafor to mobilize stem cells; the first clinical trial in patients with multiple myeloma (initial data expected in <FONT
STYLE="white-space:nowrap">mid-2021);</FONT> the first clinical trial with matched donors and patients with acute myeloid leukemia (AML), acute lymphocytic lymphoma (ALL) and myelodysplastic syndromes (MDS) (data expected in the second half of
2021); and the first clinical trial in patients with sickle cell disease (trial initiation expected in the second half of 2021) &#150; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; <FONT STYLE="white-space:nowrap">MGTA-117:</FONT> Completing GLP toxicology and GMP manufacturing of targeted conditioning
antibody-drug conjugate, <FONT STYLE="white-space:nowrap">MGTA-117;</FONT> plans to initiate clinical trial in acute myeloid leukemia and myelodysplastic syndromes in <FONT STYLE="white-space:nowrap">mid-2021</FONT> &#150; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Five abstracts from across Magenta&#146;s pipeline, including four oral presentations, will be presented at the Transplantation and
Cellular Therapy (TCT) Annual Meeting, to be held virtually February <FONT STYLE="white-space:nowrap">8-12,</FONT> 2021 &#150; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Magenta also has announced the appointment of experienced biotech executive Alison Lawton to its Board of Directors &#151; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>&#151; Ended 2020 with cash reserves of&nbsp;approximately $145&nbsp;million that are expected to fund the current operating plan
into&nbsp;2023 &#151; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CAMBRIDGE, Mass. &#150; January&nbsp;11, 2021 -<B>&nbsp;Magenta Therapeutics</B>&nbsp;(NASDAQ: MGTA), a clinical-stage
biotechnology company developing novel medicines to bring the curative power of immune and blood systems reset via stem cell transplant to more patients, today highlighted progress across its stem cell mobilization and collection and targeted
conditioning programs, and set expectations for 2021. These updates will be discussed during a webcast presentation at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January&nbsp;14 at 7:50 a.m. PST / 10:50 a.m. EST. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I&#146;m exceptionally proud of the entire Magenta team who continued to adapt and execute across our portfolio, despite the disruptions that
characterized 2020. This past year, we continued to drive our vision to bring immune and blood systems reset to more patients. We announced four pipeline-expanding </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
partnerships, presented clinical and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> data across our pipeline and secured the capital that we expect can fund our operations into 2023. We
continue to advance four ongoing and planned clinical trials that we believe can advance our portfolio in 2021 and, for <FONT STYLE="white-space:nowrap">MGTA-145</FONT> specifically, can provide <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> for stem cell mobilization across multiple diseases and the first clinical data for <FONT STYLE="white-space:nowrap">MGTA-117</FONT> targeted conditioning,&#148; said Jason Gardner, D. Phil.,
President and Chief Executive Officer, Magenta. &#147;I am also delighted to welcome Alison Lawton&#146;s return to Magenta&#146;s Board of Directors. Alison brings extensive experience and leadership in both regulatory and business arenas,
essential as the Magenta portfolio advances. We look forward to building on the momentum generated in 2020 as we relentlessly focus on execution.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Stem Cell Mobilization and Collection </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT
STYLE="white-space:nowrap">MGTA-145:</FONT> Three Phase 2 Clinical Trials Ongoing or Planned </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Autologous Stem Cell Transplant of Multiple
Myeloma Patients.</B> Previously announced ongoing enrollment continues for the Phase 2 investigator-initiated clinical trial of <FONT STYLE="white-space:nowrap">MGTA-145,</FONT> used in combination with plerixafor, to mobilize and collect stem
cells for autologous stem cell transplantation in multiple myeloma patients at Stanford University. Magenta expects that this trial will provide data on stem cell mobilization and collection, durability of engraftment in transplanted patients and
disease outcomes, including progression-free survival. Initial data from the study are expected from <FONT STYLE="white-space:nowrap">mid-2021.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Allogeneic Donor Stem Cell Mobilization and Collection for Stem Cell Transplant in AML, ALL and MDS Patients</B>. Through a collaboration with the National
Marrow Donor Program<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>/Be The Match<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Magenta plans to initiate, within the next several weeks, a Phase 2 clinical trial using <FONT
STYLE="white-space:nowrap">MGTA-145</FONT> to mobilize and collect stem cells from allogeneic donors for transplant in patients with AML, ALL and MDS. This clinical trial will evaluate stem cell mobilization, collection, cell quality, engraftment
and disease outcomes, including Graft-versus-Host Disease (GvHD), which is of particular importance in the allogeneic transplant setting. Initial data from this clinical trial are expected in the second half of 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sickle Cell Disease &#150; Stem Cell Mobilization and Collection; Cell Characterization; <FONT STYLE="white-space:nowrap">Pre-Clinical</FONT> Gene
Modification Model.</B> In collaboration with bluebird bio, Magenta plans to initiate a Phase 2 clinical trial in the second half of 2021 to evaluate <FONT STYLE="white-space:nowrap">MGTA-145,</FONT> in combination with plerixafor, for the
mobilization and collection of stem cells in adults and adolescents with sickle cell disease (SCD). Each party will characterize the cells and Magenta plans to gene-correct the cells and transplant them into established <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> disease models to evaluate engraftment. Data from this clinical trial could provide <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> for <FONT
STYLE="white-space:nowrap">MGTA-145,</FONT> in combination with plerixafor, as the preferred mobilization regimen for patients with SCD and, more broadly, across all gene therapy applications where safe, reliable and rapid mobilization of quality
stem cells for gene-modification and transplant are necessary components. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>About <FONT STYLE="white-space:nowrap">MGTA-145</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta is developing <FONT STYLE="white-space:nowrap">MGTA-145</FONT> in combination with plerixafor to harness complementary mechanisms to mobilize
hematopoietic stem cells (HSCs) for collection and transplantation. This combination has the potential to be the preferred mobilization regimen for safe, rapid and reliable mobilization and collection of HSCs and could improve outcomes in autologous
and allogeneic stem cell transplantation. <B><U> </U></B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Targeted Conditioning </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">MGTA-117:</FONT> Plans to Initiate Phase 1 in <FONT STYLE="white-space:nowrap">mid-2021;</FONT> Initial Safety and
Pharmacokinetics (PK) data to be assessed in the fourth quarter of 2021</I></B> <B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AML and MDS.</B> Magenta is completing its <FONT
STYLE="white-space:nowrap">IND-enabling</FONT> GLP toxicology studies and GMP manufacturing process for <FONT STYLE="white-space:nowrap">MGTA-117,</FONT> the first antibody-drug conjugate (ADC) candidate from the company&#146;s research platform for
targeted conditioning of patients prior to receiving a stem cell transplant for blood cancers or gene therapy drug products. Later this month, Magenta expects to complete its initial discussions with the U.S. Food and Drug Administration regarding
the design of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trial. Magenta expects to file an IND and, upon approval, plans to initiate a Phase 1 clinical trial in <FONT
STYLE="white-space:nowrap">mid-2021</FONT> to assess the safety and PK in the first cohort of patients in the fourth quarter of 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>About <FONT
STYLE="white-space:nowrap">MGTA-117</FONT> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">MGTA-117,</FONT> Magenta&#146;s most advanced conditioning program, is
a CD117-targeted antibody engineered for the transplant setting and conjugated to amanitin, a payload <FONT STYLE="white-space:nowrap">in-licensed</FONT> from Heidelberg Pharma. <FONT STYLE="white-space:nowrap">MGTA-117</FONT> is designed to
precisely deplete only hematopoietic stem and progenitor cells to clear space in the bone marrow prior to transplant, which supports long-term engraftment and disease outcomes in patients. <FONT STYLE="white-space:nowrap">MGTA-117</FONT> has shown
high selectivity, potent efficacy, wide safety margins and broad tolerability in <FONT STYLE="white-space:nowrap">non-human</FONT> primate models. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Cash Guidance </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With focused allocation of
resources on the Company&#146;s clinical trials and advancement of its research platform, the Company now believes its cash position will fund its operations into the first quarter of 2023. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Alison Lawton Background </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Lawton is an executive leader with more than 30 years of experience in biopharma. She served as President and Chief Executive Officer of Kaleido
Biosciences, Inc. (Nasdaq: KLDO) from August 2018 to June 2020, and served as President and Chief Operating Officer from December 2017 to August 2018. Prior to joining Kaleido Biosciences, Inc., Ms.&nbsp;Lawton served as Chief Operating Officer at
Aura Biosciences, Inc., an oncology therapeutics company, from January 2015 until December 2017, and, prior to joining Aura, served as a consultant to Aura from March 2014 to December 2014. From January 2013 to January 2014, Ms.&nbsp;Lawton served
as Chief Operating Officer at OvaScience Inc., a life sciences company. From 2014 to 2017, Ms.&nbsp;Lawton served as a biotech consultant for various companies, including as Chief Operating Officer consultant at X4 Pharmaceuticals. Prior to that,
Ms.&nbsp;Lawton spent more than 20 years in various positions of increasing responsibility including Senior VP and General Manager of Biosurgery and prior, Senior VP of Market Access at Genzyme Corporation, a global biopharmaceutical company, and
subsequently at Sanofi S.A., also a global biopharmaceutical company, following the acquisition of Genzyme by Sanofi in 2011. Additionally, Ms.&nbsp;Lawton previously served two terms as the industry representative on the U.S. Food&nbsp;&amp; Drug
Administration&#146;s Cell&nbsp;&amp; Gene Therapy Advisory Committee and as Chairman of the Board of the Regulatory Affairs Professional Society. Ms.&nbsp;Lawton currently serves on the boards of directors of ProQR Therapeutics N.V., X4
Pharmaceuticals Inc. and Aeglea Biotherapeutics Inc. Ms.&nbsp;Lawton previously served on the boards of directors of Magenta Therapeutics, Kaleido Biosciences Inc., Verastem, Inc., CoLucid Pharmaceuticals, Inc. prior to its acquisition by Eli Lilly
and Cubist Pharmaceuticals, Inc. prior to its acquisition by Merck&nbsp;&amp; Co. Ms.&nbsp;Lawton holds a B.Sc. in pharmacology from Kings College, University of London. <B><U> </U></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Upcoming Presentations at the 2021 Transplantation and Cellular Therapy (TCT) Annual Meeting </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Title:</U></B> <FONT STYLE="white-space:nowrap">MGTA-145</FONT> / Plerixafor-Mediated HSC Mobilization and Intravenous HDAd5/35++ Vector Injection into
Mice Allows for Efficient In Vivo HSC Transduction and Stable Gene Marking in Peripheral Blood Cells (Oral Abstract, #16) <B><U> </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Presenting
Author:</U></B> Chang Li, Ph.D., Division of Medical Genetics, Department of Medicine, University of Washington <B><U> </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Date and Time of
Oral Presentation:</U></B> Monday, February&nbsp;8, 2021, 2:30 PM CST <B><U> </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Title:</U></B>
<FONT STYLE="white-space:nowrap">MGTA-145,</FONT> In Combination with Plerixafor in a Phase 1 Clinical Study, Mobilizes Large Numbers of Hematopoietic Stem Cells and a Graft with Potent Immunosuppressive Properties for Autologous and Allogeneic
Transplant (Oral Abstract, #35) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Presenting Author:</U></B> Kevin Goncalves, Ph.D., Magenta Therapeutics <B><U> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Date and Time of Oral Presentation:</U></B> Tuesday, February&nbsp;9, 2021, 3:00 PM CST </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B><U>Title:</U></B> <FONT STYLE="white-space:nowrap">MGTA-456,</FONT> A CD34 Expanded Cord Blood Product, Permits Selection of Better HLA Matched Units and Results in Rapid Hematopoietic
Recovery, Uniform Engraftment and Reduced Graft-Versus-Host Disease in Adults with High-Risk Hematologic Malignancies (Oral Abstract, #31) <B><U> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Presenting Author:</U></B> Heather Stefanski, M.D., Ph.D., Assistant Professor, Department of Pediatrics, University of Minnesota <B><U> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Date and Time of Oral Presentation:</U></B> Tuesday, February&nbsp;9, 2021, 3:00 PM CST </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Title:</U></B> A Single Dose of a Novel Anti-Human CD117-Amanitin Antibody Drug Conjugate (ADC) Engineered for a Short Half-life Provides Dual
Conditioning and Anti-Leukemia Activity and Extends Survival Compared to Standard of Care in Multiple <FONT STYLE="white-space:nowrap">Pre-clinical</FONT> Models of Acute Myeloid Leukemia (AML) (Oral Abstract, #53) <B><U> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Presenting Author:</U></B> Leanne Lanieri, M.S., Magenta Therapeutics <B><U> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Date and Time of Oral Presentation:</U></B> Wednesday, February&nbsp;10, 2021, 3:00 PM CST <B><U> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Title:</U></B> Targeted CD45 Antibody Drug Conjugate Enables Full Mismatch Allogeneic Hematopoietic Stem Cell Transplantation in a Murine HSCT Model as
a Single Agent (AML) (Poster #242) <B><U> </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Lead Author:</U></B> Sharon Hyzy, M.S., Magenta Therapeutics </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Magenta Therapeutics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta Therapeutics&nbsp;is
a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancer, genetic diseases and autoimmune diseases. Magenta is combining leadership
in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant world to revolutionize immune reset for more patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta is based in&nbsp;Cambridge, Mass.&nbsp;For more information, please visit<B>&nbsp;www.magentatx.com</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follow Magenta on Twitter: @magentatx. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may contain forward-looking statements and information within the meaning of The Private Securities Litigation Reform Act of 1995 and other
federal securities laws, including express or implied statements regarding Magenta&#146;s future expectations, plans and prospects, including, without limitation, statements regarding expectations and plans for presenting clinical data, projections
regarding our long-term growth, cash, cash equivalents and marketable securities, the anticipated timing of our clinical trials and regulatory filings, the development of our product candidates and advancement of our clinical programs, the timing,
progress and success of our collaborations, as well as other statements containing words such as &#147;may,&#148; &#147;will,&#148; &#147;could&#148;, &#147;should,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148;
&#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;projects,&#148; &#147;seeks,&#148; &#147;endeavor,&#148; &#147;potential,&#148; &#147;continue&#148; or the negative of such words or other similar
expressions that can be used to identify forward-looking statements. The express or implied forward-looking statements included in this press release are only predictions and are subject to a number of risks, uncertainties and assumptions,
including, without limitation: uncertainties inherent in clinical studies and in the availability and timing of data from ongoing clinical studies; whether interim results from a clinical trial will be predictive of the final results of the trial;
whether results from <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies or earlier clinical studies will be predictive of the results of future trials; the expected timing of submissions for regulatory approval or review by governmental
authorities; regulatory approvals to conduct trials or to market products; whether Magenta&#146;s cash resources will be sufficient to fund Magenta&#146;s foreseeable and unforeseeable operating expenses and capital expenditure requirements; risks,
assumptions and uncertainties regarding the impact of the continuing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on Magenta&#146;s business, operations, strategy, goals and anticipated timelines, Magenta&#146;s ongoing and planned <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> activities, Magenta&#146;s ability to initiate, enroll, conduct or complete ongoing and planned clinical trials, Magenta&#146;s timelines for regulatory submissions and Magenta&#146;s financial
position; and other risks concerning Magenta&#146;s programs and operations set forth under the caption &#147;Risk Factors&#148; in Magenta&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed on March&nbsp;3, 2020, as
updated by Magenta&#146;s most recent Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and its other filings with the Securities and Exchange Commission. In light of these risks, uncertainties and assumptions, the
forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely upon
forward-looking statements as predictions of future events. Although Magenta believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the future results, levels of activity, performance or
events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, except as required by law, neither Magenta nor any other person assumes responsibility for the accuracy and completeness of the forward-looking
statements included in this press release. Any forward-looking statement included in this press release speaks only as of the date on which it was made. We undertake no obligation to publicly update or revise any forward-looking statement, whether
as a result of new information, future events or otherwise, except as required by law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta Therapeutics: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lyndsey Scull, Director, Corporate
Communications, Magenta Therapeutics </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">202-213-7086</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">lscull@magentatx.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor inquiries: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jill Bertotti, W2O Group </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">714-225-6726</FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">jbertotti@w2ogroup.com </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Media inquiries: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dan Budwick </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1AB </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">dan@1abmedia.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mgta-20210111.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 1/11/2021 5:04:54 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:mgta="http://www.magentatx.com/20210111"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.magentatx.com/20210111"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgta-20210111_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgta-20210111_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mgta-20210111_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 1/11/2021 5:04:54 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mgta-20210111_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 1/11/2021 5:04:54 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="mgta-20210111.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g86590g0110020022160.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g86590g0110020022160.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ -X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZHYIXK>)
MI9I%CC7JS' %1WUY%86<ES,<(@S[D]@*\VN;W4/%6MBR@^9Q\VS/[N!/5O?]
M332N8U:RA[JU;.LN_'&DVS%8_.GQW1<#\S52/XC:46Q-;W,0]=H8#\C6AIOA
M'3+&,&:(7<W\4DHX_!>@IVIV?AFV6./48+"'SFV1[U"EC[4]!1C7EV]#0T[6
M+#5HC)8W4<P'W@I^9?J.HJ]7G^K^!)[&3^TO#-S+!=1?,(2WWO93_0\5N>$/
M$X\0V4D<Z"'4;8[+B'&.?[P'I_(TFNQ<9N]I;G2444A('4@4C06BFM(BXW.H
MSTR<9I2RJ"6( '4GB@!:*165EW*P(/<'-!( R3@>IH 6BD#*PRK CU!S2T %
M%-$B%R@=2PZ@'D4H8'H0?QH 6BD+!022 !U)I%='7<C!AZ@YH =12$@=2!2-
M(BD!G4$],G&: '445YG\./B)JOB_Q'K.G:A;V<4-B"8VA# GYRO.2>PH ],H
MHR*;O0MM#+N],\T .H%% H 6BBB@#@?B%JS6RQVZGA%WX]6/ _*I?AC:(GA^
M>]/S37,[;V/7"\ ?S/XUSWQ.#)J\>?NNH8?@,5?^&?B"WB@DT6YD6.0R&2 L
M<!\]5^O?\:V:_=Z'GPDOK#YCTJL#Q+H6CZG'#>:NYCBM"6W^9M&#C(/MP*V+
MB]M;0 W-S##GIYCA<_G7->.M-NM=\-J-,(G,<HE*(P/F 9Z>I'6LH[GL89/V
ML?>Y4^IMZ9K6F:LC?V==Q3B/A@AY7TXKE_$5J- \7Z7XCMALANI19WRCH=W"
ML?\ /85D_#SP_JMGK<E_=6TMK L1CQ*-I<DCM[8KJ_'4/G>$+L8^='B=/9A(
MN*IJSL&/H4Z-5PIRYDNITE>-_M#2/'X?T4J[IF[?.UB./+/I7LGUKQ?]HO\
MY%W1?^OJ3_T6:@YS$UCX7:UJG@O_ (2K4=?DFU*.R6X6T*_NTB500BG/!"CT
MZ_G5;P7H'B#XJZ)]GU7Q'<P:3I>(8E4;VE<\_-D\X! R<]J]BO?^23S_ /8$
M/_HFN)_9Y_Y%'5/^OW_VFM(9SWPQEU7PC\6;OP=->-/:-YB.N3LW*N]74'H2
M.OU]J[GX@_#ZX\6:Q!=S^)Y-,TI(-DD!8[2^3R 2%&1USZ5QNF_\G0W/_723
M_P!)Q534;3_A87QRO-#UR^FCTZT:1(;='VY" ?*O8$Y))ZXH S=;TO4_A'K&
MFZMHOB W^GW#D-M;Y7VX+(Z@D$$'@UZ'\8_&UUHGA2PATF9H;C5<GS4.'2(*
M"=OH3D#/UKSOXO\ @KPYX-CTZ/17F2XN"YEMY)]X" ##8/(YXKI/C3HUQ/X-
M\-:S C,EG$L4Q'.P.J[2?;*X_$4 -T7X*:O#I5OK4/B6>TUXH)XT13M5R,A6
M;.3Z$]/8U5^"=Q?7'Q)UYM09_M1MI#,A)PLGFKNP.W.:[33?C3X4/AB&[N[M
MH[](@)+$1L9"X&,+Q@@GH<UQ7P2N9;WXF:_=W$1BFGMY)7C(QL+2J2/PS0!-
MKEQJWQ6^)EUX8M;^6ST/3BPE,><-L.UF(_B);@ \ <U2US2=2^"GB33-3TS5
M+BZTB[<K-#,<;@,;E8#@G!R#@'BL72O#EO)\5=7\/ZIK5[H[O/+Y,\$GEF5B
MVY5)]"IR/>NXU;X0:%'):VFK^.=2WW,GEV\5U,K%W(_A#=Z (?V@KG=IGAN>
M"5Q'(TS@JQ&X%4(JCK_PKUK4?"LOBK4O$$EQJRVHN3:E,1H@7.Q3G((7VZ_G
M5CX_6RV>A^%[56++#YL88]3M1!G]*]6UG_DGM_\ ]@I__11H \^^&T]Y\0?A
M3J>A:AJ$RR1R?9DN_O2"/"LO7J1R.O2O-O /@)?&6O:OIK:K<67V)3B6),F3
MYRO/(],UZ-^SO_R+6K_]?:_^@"L7X'SPQ>._$XDE1"R-M#,!G$K9Q0!ZGK_A
M6]U#P$GA_3M7EL[B***-;P,5+!, [L'." >,UY)K?PC_ +(TBZU32/&!O-2L
MXS,\2L%9@HRVTJQ(. >M=)\>]=O;/0M)L+*Y:*VU"1S/)&V-ZJ!@9'\/S9/K
MBJ^K?"3P7HG@2XU:2[N?/AM#*MX+C E<K\N!C&"<<>] '6_"'Q1>^*/!"3ZC
M(9;NUF:W>8]9  "K'WP<'Z5WHKR7]GW/_"$W^>OV]O\ T!*]:%,0M%%% '#?
M$K1GO='34($+26ARX Y*'J?PZUY_X9BA2XO-4GC65--@-PL;='DR F?;)S^%
M>[LH92I ((P0:XR;P'!%<:B+"016NH6[120D?ZM\Y5E]L]JTC.RLS%4(NO&<
MMKZGDUY=7&HW3W5Y,TT[G+,YS^ ]!6YX,UZYT77;>)9&-I<2".6(GY>3@,!V
M(-8U_87>E7;VM] \,J''S#@^X/<5O>"_#MUJ^M6]TT+K8V\@D>1A@,1R%'KS
M6KM8_0<6\-]4=[<MM#VRLC68_MTUCIXY#SK/+[1QG=^K;1^=:K,57@$D]A44
M%OY;O,^&FDQN/H!T4>PKF/A">N3\=^ [/QY8VEK>7EQ;+;2&16@"DDE<<Y%=
M956]U*TTU%>\G6%&. 6SUH&DWL5YM'BF\-/HAE<0M:?9#(,;MNS;GTSBLCP-
MX(M/ NF7%C9W<]RD\WFEI@ 0=H&.![5T,5[;3&,1RJQD3S$'<J.,_K5>;6]-
M@CADDNXPDZEHCR=X'<8HL"3.;M_AQ8V_Q$D\9+?7)NG9B8"%\L939Z9Z51\8
M_"32?%FKC5XKVYTS4#CS);< B3' )'9L=P:[2?6=/M98XY[N.-Y%#*&.,@]#
M[?C5B:[@MWA665$:9]D8)^^V,X'Y46"S/+[CX#Z'=:?'%/JNHR7F\O->NP:2
M3C 7G.%'6NF\:^(;3P3X/ADNM.DU.VS':M#MR&3&"6X(Q@=^,\5T=UJUC97"
M07-U'%*XRJL<<9QG\Z2YU/3X;@6=Q/&)7 _=$$Y!X&?K18+,\)@\:?"/2Y3J
MNG>&+@ZBGSQ121_(K^V6*KSW K:^"&BZE<:MK/B[4(6ACO\ <L6X$>86?>S
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MY@,@D 8X^E=,**!0 M%%% "4444 1R00S "6)) .F]0<?G3E144*JA5'0 8
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, % HH% "T444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d86590d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mgta-20210111.xsd" xlink:type="simple"/>
    <context id="duration_2021-01-11_to_2021-01-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690585</identifier>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2021-01-11_to_2021-01-11">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-01-11_to_2021-01-11"
      id="Hidden_dei_EntityCentralIndexKey">0001690585</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-01-11_to_2021-01-11">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-01-11_to_2021-01-11">2021-01-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-01-11_to_2021-01-11">MAGENTA THERAPEUTICS,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-01-11_to_2021-01-11">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-01-11_to_2021-01-11">001-38541</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-01-11_to_2021-01-11">81-0724163</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-01-11_to_2021-01-11">100 Technology Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-01-11_to_2021-01-11">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-01-11_to_2021-01-11">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-01-11_to_2021-01-11">02139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-01-11_to_2021-01-11">(857)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-01-11_to_2021-01-11">242-0170</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-01-11_to_2021-01-11">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-01-11_to_2021-01-11">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-01-11_to_2021-01-11">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-01-11_to_2021-01-11">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-01-11_to_2021-01-11">Common Stock, $0.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-01-11_to_2021-01-11">MGTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-01-11_to_2021-01-11">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-01-11_to_2021-01-11">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2021-01-11_to_2021-01-11">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140374319489192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001690585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 11,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MAGENTA THERAPEUTICS,&#160;INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-0724163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Technology Square<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">242-0170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MGTA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    (  ]"*U(<.&7J/P$  #P"   /
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MDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    "  /0BM2)!Z;HJT   #X 0
M&@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I
M0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LID
MR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\
M./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6
M?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ #T(K4F60>9(9 0
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M<',O87!P+GAM;%!+ 0(4 Q0    (  ]"*U*7[=Z:[@   "L"   1
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M96QS+RYR96QS4$L! A0#%     @ #T(K4APX9>H_ 0  / (   \
M     ( !AP\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  ]"*U(D'INB
MK0   /@!   :              "  ?,0  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    (  ]"*U)ED'F2&0$  ,\#   3
M  "  =@1  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "(3
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d86590d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d86590d8k.htm">d86590d8k.htm</File>
    <File>d86590dex991.htm</File>
    <File>mgta-20210111.xsd</File>
    <File>mgta-20210111_lab.xml</File>
    <File>mgta-20210111_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d86590d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d86590d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mgta-20210111_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mgta-20210111_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mgta-20210111.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mgta",
   "nsuri": "http://www.magentatx.com/20210111",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d86590d8k.htm",
      "contextRef": "duration_2021-01-11_to_2021-01-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d86590d8k.htm",
      "contextRef": "duration_2021-01-11_to_2021-01-11",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.magentatx.com//20210111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-21-005827-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-005827-xbrl.zip
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M76\M!\=X)G!:]=J79J/=J+?(Y>T5J?]1^W1Y>UTGM;N;FT:KU;B[?12,A7W
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M   0    9#@V-3DP9&5X.3DQ+FAT;>U=ZU,;QY;_3A7_0Y>S>\NN*\D(&S^
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MM>60*HVR3+ EAA;FX[SW*Q[R?ZKI?P%02P,$%     @ #T(K4F._4^-D P
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M  1FEN?)5#\0%&SVX;7$YHB.TO288'<X3#KO0:10_^Q >/$8&Z7OY GD\3@
MZ& P($&Z1JEPJW&TUD])(^QI6Y%O#AD%/F3:"YDY9\2X=OQ*F_*23U@MT4^M
M_JV9%!/!BZ"%?5YBFE=T5C4<,U/N;EG);<5R?EB-L"$WI0*CH^3'IYNOH5>C
M"P\ ".TKRDH;!TT7W^@\#->."OA?<5>XV%_%] ASD*"Q"-1&VENJ#N3%1+I^
M>!:113/M3<1N:WU_B)<SL(W#KK%Y=C;6EX//Q<#G@K[;*Q=/ELM_P$2KVY>2
MZ6W(0PAM'%-_B)?SNE=YUD;\^3VBF,C#$CYKCI[(V0%$EOB7=DIOR?FZG.YT
MO[X56Z_!)U-*N^"HSX15E5 3W5[AI1^PK)NR$9] V,89,[G1DN_>V:0RNN+&
M"7S EH/:&+@W?#*,_ L6=SOPIV3C!'=@I_+$P>KH>S%!")<W2WH=U@GGP3=>
M#%Z.7P),+DS[]AQ&%O,N>ZOC?PZW,OS0<!%BP^N!9=L>]9>>UL'!>S]WJ '^
M\&UTO>/Q6KQ>Q+&95KJ<-RPO=5[[%[+[_T$5'Q5RFU]C:YDR\(I X#,W0O6?
M>ZDO6'8\"XY?IB+T+TW]'WZX=A;Z1Z8*:,Q!S]XY63>R;K^VO/BL+L(Y9S*O
MY2+K+;C5V 5<K]?^R"6S[;CVMJM8-\=D?9#;F_[ -U?-PL&?OP!02P,$%
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MA=XR?_(EW<63/WRB]_P'4$L#!!0    (  ]"*U+Z6#6.T@0  ,XL   5
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M.3!D.&LN:'1M4$L! A0#%     @ #T(K4N.[9>3T&P  L6D  !
M     ( !8 \  &0X-C4Y,&1E>#DY,2YH=&U02P$"% ,4    "  /0BM28[]3
MXV0#   I#   $0              @ &"*P  ;6=T82TR,#(Q,#$Q,2YX<V10
M2P$"% ,4    "  /0BM2:'.I:Y$&   Y1P  %0              @ $5+P
M;6=T82TR,#(Q,#$Q,5]L86(N>&UL4$L! A0#%     @ #T(K4OI8-8[2!
MSBP  !4              ( !V34  &UG=&$M,C R,3 Q,3%?<')E+GAM;%!+
4!08     !0 % #X!  #>.@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
